Inovio Announces Analysis Of VGX-3100 Phase 2b Data
Inovio Pharmaceuticals, Inc announced that post-hoc analysis of data generated from its phase 2b trial...
OSE Immunotherapeutics to Resume Accrual in Phase 3 Clinical Trial of Tedopi® in Advanced...
OSE Immunotherapeutics announces that the Independent Data Monitoring Committee (IDMC) has recommended to the trial’s...
CRF Health’s TrialMax Touch® Selected by Leading Specialty Pharmaceutical Company for Pediatric Rare Disease...
CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the...
Cmed to Demonstrate how encapsia® Transforms Clinical Trial Data Management, Capture and Reporting at...
Cmed, an oncology focused, innovative technology-led CRO, announced that it will showcase its encapsia® clinical...
Direct-to-Patient Solutions Assuring Patient Participation and Retention in Clinical Trials
The average cost of bringing a new drug to market is $2.6 billion, according to...
Cmed to Showcase Advanced Data Insights and Analytics Capabilities of encapsia® Clinical Data Suite...
Cmed, an innovative technology-led CRO, will demonstrate its encapsia® clinical data suite at Partnerships in...
Asia’s increasing levels of clinical trial industry competition are to your benefit
Biotechnology and pharmaceutical companies within the United States and Europe face an increasing number of hurdles when undertaking...
New centre is tackling manufacturing challenge of cell therapy field
Stem cell science has made huge progress since the early 1960s when Canadian researchers James...
Chi-Med Reports Preliminary Phase II data on Fruquintinib Combination in First-Line Lung Cancer
Hutchison China MediTech Limited reported preliminary clinical activity, safety, and tolerability data of fruquintinib, an...
MC2 Therapeutics A/S Announces First Patient Dosed in Pivotal US Phase 3 Trial in...
MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company today announced that first patient...
